Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBαNFκB and Enhancing Nrf2HO-1
المؤلفون المشاركون
Liu, Huang-Jun
Liao, Hai-Han
Yang, Zheng
Tang, Qi-Zhu
Zhu, Jin-xiu
Feng, Hong
Ni, Jian
Zhang, Nan
Chen, Si
Deng, Wei
المصدر
Oxidative Medicine and Cellular Longevity
العدد
المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-14، 14ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2017-09-24
دولة النشر
مصر
عدد الصفحات
14
التخصصات الرئيسية
الملخص EN
Diabetic cardiomyopathy (DCM) is associated with a greater risk of mortality in patients with diabetes mellitus.
Currently, no specific treatment has been suggested for DCM treatment.
This study demonstrated that myricetin (M) attenuated DCM-associated cardiac injury in mice subjected to streptozotocin (SZT) and in neonatal rat cardiomyocytes (NRCM) challenged with high glucose.
In vivo investigation demonstrated 6 months of M treatment (200 mg/kg/d) significantly alleviated cardiac hypertrophy, apoptosis, and interstitial fibrosis.
Mechanically, M treatment significantly increased the activity of Nrf2/HO-1 pathway, strengthening antioxidative stress capacity evidenced by reversed activities of GPx and SOD, and decreased MDA production.
M treatment also inhibited IκBα/NF-κB pathway, resulting in reduced secretion of inflammation cytokines including IL-1β, TNF-α, and IL-6.
Besides, the TGFβ/Smad3 signaling was also blunted in DCM mice treated with M.
These beneficial effects of M treatment protected cardiomyocytes from apoptosis as shown by decreased TUNEL-positive nucleus, c-caspase 3, and Bax.
Similar effects of M treatment could be reproduced in NRCM treated with high glucose.
Furthermore, through silencing Nrf2 in NRCM, we found that the regulation of IκBα/NFκB by M was independent on its function on Nrf2.
Thus, we concluded that M possesses potential protective effects on DCM through inhibiting IκBα/NFκB and enhancing Nrf2/HO-1.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Liao, Hai-Han& Zhu, Jin-xiu& Feng, Hong& Ni, Jian& Zhang, Nan& Chen, Si…[et al.]. 2017. Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBαNFκB and Enhancing Nrf2HO-1. Oxidative Medicine and Cellular Longevity،Vol. 2017, no. 2017, pp.1-14.
https://search.emarefa.net/detail/BIM-1196028
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Liao, Hai-Han…[et al.]. Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBαNFκB and Enhancing Nrf2HO-1. Oxidative Medicine and Cellular Longevity No. 2017 (2017), pp.1-14.
https://search.emarefa.net/detail/BIM-1196028
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Liao, Hai-Han& Zhu, Jin-xiu& Feng, Hong& Ni, Jian& Zhang, Nan& Chen, Si…[et al.]. Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBαNFκB and Enhancing Nrf2HO-1. Oxidative Medicine and Cellular Longevity. 2017. Vol. 2017, no. 2017, pp.1-14.
https://search.emarefa.net/detail/BIM-1196028
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1196028
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر